| Biotechnology Industry | Healthcare Sector | - CEO | JPX Exchange | JP3921300004 ISIN |
| Japan Country | 58 Employees | - Last Dividend | 26 Sep 2013 Last Split | - IPO Date |
Immuno-Biological Laboratories Co., Ltd., founded in 1982 and headquartered in Fujioka, Japan, is a company at the frontier of the immunological research sector. It specializes in the research, development, manufacturing, and global distribution of various immunological research reagents. The company's mission encompasses supporting cutting-edge research in critical areas such as Alzheimer's disease, metabolic syndrome, and cancer, thereby contributing significantly to the advancement of life sciences and medical research. Immuno-Biological Laboratories also diversifies its offerings through the provision of customized services, ranging from antibody production to the development of specific ELISA (Enzyme-Linked Immunosorbent Assay) systems tailored to the unique requirements of their clients, ensuring a wide-reaching impact across various research fields.
ELISA kits are provided by Immuno-Biological Laboratories as a comprehensive analytical tool designed for the quantitative measurement of targeted substances. These kits are fundamental in facilitating research across an array of domains, including but not limited to the study of diseases such as Alzheimer's and various forms of cancer. The versatility of these kits makes them an essential asset for research laboratories worldwide.
LipoSEARCH offers a specialized analytical service for the profiling and analysis of lipoproteins using the gel-filtration high-performance liquid chromatography method. This service can analyze tiny clinical samples, including plasma or serum from both small animals and humans, making it invaluable for research in lipid metabolism, drug development for lifestyle-related diseases, the development of functional foods, and clinical studies.
LipoTEST is a diagnostic and health check tool utilized in animal clinics, providing a means to support diagnostics and routine health assessments. This service emphasizes the company's commitment to veterinary health care and the role of diagnostics in preventive medicine.
These services are tailored for the detection and analysis of biomarkers related to lifestyle diseases, offering crucial support for clinical research, disease diagnostics, and the development of therapeutic strategies. Immuno-Biological Laboratories leverages its expertise to provide customized biomarker solutions, facilitating significant advancements in healthcare research and diagnostics.
Immuno-Biological Laboratories utilizes cutting-edge biotechnology in the form of transgenic silkworms for the production of various proteins. This innovative approach serves multiple purposes, including the manufacturing of antibodies for research and diagnostic products, human collagen for cosmetic materials, and proteins for pharmaceutical applications. The use of transgenic silkworms underscores the company’s dedication to employing sustainable and efficient production methods in biotechnology.